Zeng L - Search Results

1

The Failure Patterns of Nasopharygeal Carcinoma After Intensity-Modulated Radiotherapy and Implications for Surveillance.

Tian Y, Huang WZ, Zeng L, Bai L, Han F, Lan Y. Tian Y, et al. Among authors: zeng l. Cancer Manag Res. 2022 Oct 5;14:2813-2823. doi: 10.2147/CMAR.S347864. eCollection 2022. Cancer Manag Res. 2022. PMID: 36221292 Free PMC article.

2

Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma.

Zeng L, Sun XM, Chen CY, Han F, Huang Y, Xiao WW, Liu S, Tian YM, Deng XW, Lu TX. Zeng L, et al. Head Neck. 2014 May;36(5):687-93. doi: 10.1002/hed.23359. Epub 2013 Oct 17. Head Neck. 2014. PMID: 23606573

3

Comparing treatment outcomes of different chemotherapy sequences during intensity modulated radiotherapy for advanced N-stage nasopharyngeal carcinoma patients.

Sun X, Zeng L, Chen C, Huang Y, Han F, Xiao W, Liu S, Lu T. Sun X, et al. Among authors: zeng l. Radiat Oncol. 2013 Nov 13;8:265. doi: 10.1186/1748-717X-8-265. Radiat Oncol. 2013. PMID: 24219818 Free PMC article.

4

Prognostic factors in nasopharyngeal carcinoma with synchronous liver metastasis: a retrospective study for the management of treatment.

Tian YM, Zeng L, Wang FH, Liu S, Guan Y, Lu TX, Han F. Tian YM, et al. Among authors: zeng l. Radiat Oncol. 2013 Nov 19;8:272. doi: 10.1186/1748-717X-8-272. Radiat Oncol. 2013. PMID: 24252126 Free PMC article.

5

Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors.

Zeng L, Tian YM, Sun XM, Chen CY, Han F, Xiao WW, Deng XW, Lu TX. Zeng L, et al. Br J Cancer. 2014 Jan 7;110(1):49-54. doi: 10.1038/bjc.2013.720. Epub 2013 Nov 19. Br J Cancer. 2014. PMID: 24253503 Free PMC article.

6

Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy.

Tian YM, Tian YH, Zeng L, Liu S, Guan Y, Lu TX, Han F. Tian YM, et al. Among authors: zeng l. Br J Cancer. 2014 Jan 21;110(2):297-303. doi: 10.1038/bjc.2013.715. Epub 2013 Dec 12. Br J Cancer. 2014. PMID: 24335924 Free PMC article.

7

Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: clinical outcomes and patterns of failure in an endemic area in China.

Zeng L, Tian YM, Sun XM, Huang Y, Chen CY, Han F, Liu S, Lan M, Guan Y, Deng XW, Lu TX. Zeng L, et al. Strahlenther Onkol. 2014 Oct;190(11):993-1000. doi: 10.1007/s00066-014-0680-7. Epub 2014 May 17. Strahlenther Onkol. 2014. PMID: 24838409

8

Temporal lobe injury after re-irradiation of locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy: clinical characteristics and prognostic factors.

Liu S, Lu T, Zhao C, Shen J, Tian Y, Guan Y, Zeng L, Xiao W, Huang S, Han F. Liu S, et al. Among authors: zeng l. J Neurooncol. 2014 Sep;119(2):421-8. doi: 10.1007/s11060-014-1513-3. Epub 2014 Jul 2. J Neurooncol. 2014. PMID: 24986091

9

Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma.

Tian YM, Guan Y, Xiao WW, Zeng L, Liu S, Lu TX, Zhao C, Han F. Tian YM, et al. Among authors: zeng l. Head Neck. 2016 Feb;38(2):225-31. doi: 10.1002/hed.23880. Epub 2015 May 27. Head Neck. 2016. PMID: 25244494

10

Retrospective analysis of 234 nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis: therapeutic approaches and prognostic factors.

Zeng L, Tian YM, Huang Y, Sun XM, Wang FH, Deng XW, Han F, Lu TX. Zeng L, et al. PLoS One. 2014 Sep 23;9(9):e108070. doi: 10.1371/journal.pone.0108070. eCollection 2014. PLoS One. 2014. PMID: 25247415 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,840 results

Search Page

Filters